Prechemoradiotherapy Systemic Inflammation Response Index Stratifies Stage IIIB/C Non-Small-Cell Lung Cancer Patients into Three Prognostic Groups: A Propensity Score-Matching Analysis Article Swipe
Erkan Topkan
,
Uğur Selek
,
Ahmet Küçük
,
Veysel Haksöyler
,
Yurday Özdemir
,
Duygu Sezen
,
Hüseyin Mertsoylu
,
Ali Ayberk Beşen
,
Yasemin Bölükbaşı
,
Özgür Özyılkan
,
Berrin Pehlivan
·
YOU?
·
· 2021
· Open Access
·
· DOI: https://doi.org/10.1155/2021/6688138
YOU?
·
· 2021
· Open Access
·
· DOI: https://doi.org/10.1155/2021/6688138
Purpose. We explored the prognostic influence of the systemic inflammation response index (SIRI) on the survival outcomes of stage IIIB/C non-small-cell lung cancer (NSCLC) patients who underwent concurrent chemoradiotherapy. Methods. Present propensity score-matching (PSM) analysis comprised 876 stage IIIB/C NSCLC patients who received 1–3 cycles of platinum-based doublets concurrent with thoracic radiotherapy from 2007 to 2017. The primary and secondary objectives were the relationships between the SIRI values and overall (OS) and progression-free survival, respectively. Propensity scores were calculated for SIRI groups to adjust for confounders and to facilitate well-balanced comparability between the SIRI groups by creating 1 : 1 matched study groups. Results. The receiver operating characteristic curve analysis identified an optimal SIRI cutoff at 1.9 for OS (AUC: 78.8%; sensitivity: 73.7%; specificity: 70.7%) and PFS (AUC: 80.5%; sensitivity: 75.8%; specificity: 72.9%) and we grouped the patients into two PSM cohorts: SIRI < 1.9 (N = 304) and SIRI ≥ 1.9 (N = 304), respectively. The SIRI ≥ 1.9 cohort had significantly worse median OS ( P < 0.001 ) and PFS ( P < 0.001 ) than their SIRI < 1.9 companions. The further combination of SIRI with disease stage exhibited that the SIRI-1 (IIIB and SIRI < 1.9) and SIRI-3 (IIIC and SIRI ≥ 1.9) cohorts had the best and worst outcomes, respectively, with SIRI-2 cohort (IIIB and SIRI ≥ 1.9 or IIIC and SIRI < 1.9) being remained in between ( P < 0.001 for OS and PFS, separately). In multivariate analysis, the two- and three-laddered stratifications per the 1.9 cutoffs and SIRI groups retained their independent significance, individually. Conclusions. The SIRI ≥ 1.9 independently prognosticated significantly worse OS and PFS results and plated the stage IIIB/C patients into three fundamentally distinct prognostic groups.
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1155/2021/6688138
- https://downloads.hindawi.com/journals/jo/2021/6688138.pdf
- OA Status
- hybrid
- Cited By
- 15
- References
- 28
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W3125933111
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W3125933111Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1155/2021/6688138Digital Object Identifier
- Title
-
Prechemoradiotherapy Systemic Inflammation Response Index Stratifies Stage IIIB/C Non-Small-Cell Lung Cancer Patients into Three Prognostic Groups: A Propensity Score-Matching AnalysisWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2021Year of publication
- Publication date
-
2021-01-23Full publication date if available
- Authors
-
Erkan Topkan, Uğur Selek, Ahmet Küçük, Veysel Haksöyler, Yurday Özdemir, Duygu Sezen, Hüseyin Mertsoylu, Ali Ayberk Beşen, Yasemin Bölükbaşı, Özgür Özyılkan, Berrin PehlivanList of authors in order
- Landing page
-
https://doi.org/10.1155/2021/6688138Publisher landing page
- PDF URL
-
https://downloads.hindawi.com/journals/jo/2021/6688138.pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
hybridOpen access status per OpenAlex
- OA URL
-
https://downloads.hindawi.com/journals/jo/2021/6688138.pdfDirect OA link when available
- Concepts
-
Medicine, Propensity score matching, Internal medicine, Cohort, Lung cancer, Stage (stratigraphy), Multivariate analysis, Proportional hazards model, Hazard ratio, Oncology, Gastroenterology, Confidence interval, Biology, PaleontologyTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
15Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 1, 2024: 4, 2023: 8, 2022: 1, 2021: 1Per-year citation counts (last 5 years)
- References (count)
-
28Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W3125933111 |
|---|---|
| doi | https://doi.org/10.1155/2021/6688138 |
| ids.doi | https://doi.org/10.1155/2021/6688138 |
| ids.mag | 3125933111 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/33552158 |
| ids.openalex | https://openalex.org/W3125933111 |
| fwci | 1.46764091 |
| type | article |
| title | Prechemoradiotherapy Systemic Inflammation Response Index Stratifies Stage IIIB/C Non-Small-Cell Lung Cancer Patients into Three Prognostic Groups: A Propensity Score-Matching Analysis |
| biblio.issue | |
| biblio.volume | 2021 |
| biblio.last_page | 9 |
| biblio.first_page | 1 |
| topics[0].id | https://openalex.org/T11355 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 1.0 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2730 |
| topics[0].subfield.display_name | Oncology |
| topics[0].display_name | Inflammatory Biomarkers in Disease Prognosis |
| topics[1].id | https://openalex.org/T10550 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.978600025177002 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2743 |
| topics[1].subfield.display_name | Reproductive Medicine |
| topics[1].display_name | Ovarian cancer diagnosis and treatment |
| topics[2].id | https://openalex.org/T12064 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9595000147819519 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2746 |
| topics[2].subfield.display_name | Surgery |
| topics[2].display_name | Intraperitoneal and Appendiceal Malignancies |
| is_xpac | False |
| apc_list.value | 2100 |
| apc_list.currency | USD |
| apc_list.value_usd | 2100 |
| apc_paid.value | 2100 |
| apc_paid.currency | USD |
| apc_paid.value_usd | 2100 |
| concepts[0].id | https://openalex.org/C71924100 |
| concepts[0].level | 0 |
| concepts[0].score | 0.9633806943893433 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[0].display_name | Medicine |
| concepts[1].id | https://openalex.org/C17923572 |
| concepts[1].level | 2 |
| concepts[1].score | 0.785233736038208 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q7250160 |
| concepts[1].display_name | Propensity score matching |
| concepts[2].id | https://openalex.org/C126322002 |
| concepts[2].level | 1 |
| concepts[2].score | 0.7180060148239136 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[2].display_name | Internal medicine |
| concepts[3].id | https://openalex.org/C72563966 |
| concepts[3].level | 2 |
| concepts[3].score | 0.5786592960357666 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q1303415 |
| concepts[3].display_name | Cohort |
| concepts[4].id | https://openalex.org/C2776256026 |
| concepts[4].level | 2 |
| concepts[4].score | 0.5245478749275208 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q47912 |
| concepts[4].display_name | Lung cancer |
| concepts[5].id | https://openalex.org/C146357865 |
| concepts[5].level | 2 |
| concepts[5].score | 0.502640962600708 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q1123245 |
| concepts[5].display_name | Stage (stratigraphy) |
| concepts[6].id | https://openalex.org/C38180746 |
| concepts[6].level | 2 |
| concepts[6].score | 0.4872704744338989 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q1952580 |
| concepts[6].display_name | Multivariate analysis |
| concepts[7].id | https://openalex.org/C50382708 |
| concepts[7].level | 2 |
| concepts[7].score | 0.4317484498023987 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q223218 |
| concepts[7].display_name | Proportional hazards model |
| concepts[8].id | https://openalex.org/C207103383 |
| concepts[8].level | 3 |
| concepts[8].score | 0.411428838968277 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q3930246 |
| concepts[8].display_name | Hazard ratio |
| concepts[9].id | https://openalex.org/C143998085 |
| concepts[9].level | 1 |
| concepts[9].score | 0.3979644775390625 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q162555 |
| concepts[9].display_name | Oncology |
| concepts[10].id | https://openalex.org/C90924648 |
| concepts[10].level | 1 |
| concepts[10].score | 0.36093902587890625 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q120569 |
| concepts[10].display_name | Gastroenterology |
| concepts[11].id | https://openalex.org/C44249647 |
| concepts[11].level | 2 |
| concepts[11].score | 0.21286830306053162 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q208498 |
| concepts[11].display_name | Confidence interval |
| concepts[12].id | https://openalex.org/C86803240 |
| concepts[12].level | 0 |
| concepts[12].score | 0.0 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[12].display_name | Biology |
| concepts[13].id | https://openalex.org/C151730666 |
| concepts[13].level | 1 |
| concepts[13].score | 0.0 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q7205 |
| concepts[13].display_name | Paleontology |
| keywords[0].id | https://openalex.org/keywords/medicine |
| keywords[0].score | 0.9633806943893433 |
| keywords[0].display_name | Medicine |
| keywords[1].id | https://openalex.org/keywords/propensity-score-matching |
| keywords[1].score | 0.785233736038208 |
| keywords[1].display_name | Propensity score matching |
| keywords[2].id | https://openalex.org/keywords/internal-medicine |
| keywords[2].score | 0.7180060148239136 |
| keywords[2].display_name | Internal medicine |
| keywords[3].id | https://openalex.org/keywords/cohort |
| keywords[3].score | 0.5786592960357666 |
| keywords[3].display_name | Cohort |
| keywords[4].id | https://openalex.org/keywords/lung-cancer |
| keywords[4].score | 0.5245478749275208 |
| keywords[4].display_name | Lung cancer |
| keywords[5].id | https://openalex.org/keywords/stage |
| keywords[5].score | 0.502640962600708 |
| keywords[5].display_name | Stage (stratigraphy) |
| keywords[6].id | https://openalex.org/keywords/multivariate-analysis |
| keywords[6].score | 0.4872704744338989 |
| keywords[6].display_name | Multivariate analysis |
| keywords[7].id | https://openalex.org/keywords/proportional-hazards-model |
| keywords[7].score | 0.4317484498023987 |
| keywords[7].display_name | Proportional hazards model |
| keywords[8].id | https://openalex.org/keywords/hazard-ratio |
| keywords[8].score | 0.411428838968277 |
| keywords[8].display_name | Hazard ratio |
| keywords[9].id | https://openalex.org/keywords/oncology |
| keywords[9].score | 0.3979644775390625 |
| keywords[9].display_name | Oncology |
| keywords[10].id | https://openalex.org/keywords/gastroenterology |
| keywords[10].score | 0.36093902587890625 |
| keywords[10].display_name | Gastroenterology |
| keywords[11].id | https://openalex.org/keywords/confidence-interval |
| keywords[11].score | 0.21286830306053162 |
| keywords[11].display_name | Confidence interval |
| language | en |
| locations[0].id | doi:10.1155/2021/6688138 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S207014961 |
| locations[0].source.issn | 1687-8450, 1687-8469 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 1687-8450 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Journal of Oncology |
| locations[0].source.host_organization | https://openalex.org/P4310319869 |
| locations[0].source.host_organization_name | Hindawi Publishing Corporation |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310319869 |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://downloads.hindawi.com/journals/jo/2021/6688138.pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Journal of Oncology |
| locations[0].landing_page_url | https://doi.org/10.1155/2021/6688138 |
| locations[1].id | pmid:33552158 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Journal of oncology |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/33552158 |
| locations[2].id | pmh:oai:cdm21054.contentdm.oclc.org:IR/9366 |
| locations[2].is_oa | False |
| locations[2].source.id | https://openalex.org/S4306401342 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | Digital Collections portal (Koç University) |
| locations[2].source.host_organization | https://openalex.org/I1351752 |
| locations[2].source.host_organization_name | Koç University |
| locations[2].source.host_organization_lineage | https://openalex.org/I1351752 |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Journal article |
| locations[2].license_id | |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Journal of Oncology |
| locations[2].landing_page_url | https://doi.org/10.1155/2021/6688138 |
| locations[3].id | pmh:oai:doaj.org/article:4842ac6b99f745ddb9cea52073fc9bff |
| locations[3].is_oa | True |
| locations[3].source.id | https://openalex.org/S4306401280 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | False |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| locations[3].source.host_organization | |
| locations[3].source.host_organization_name | |
| locations[3].source.host_organization_lineage | |
| locations[3].license | cc-by-sa |
| locations[3].pdf_url | |
| locations[3].version | submittedVersion |
| locations[3].raw_type | article |
| locations[3].license_id | https://openalex.org/licenses/cc-by-sa |
| locations[3].is_accepted | False |
| locations[3].is_published | False |
| locations[3].raw_source_name | Journal of Oncology, Vol 2021 (2021) |
| locations[3].landing_page_url | https://doaj.org/article/4842ac6b99f745ddb9cea52073fc9bff |
| locations[4].id | pmh:oai:europepmc.org:6765989 |
| locations[4].is_oa | True |
| locations[4].source.id | https://openalex.org/S4306400806 |
| locations[4].source.issn | |
| locations[4].source.type | repository |
| locations[4].source.is_oa | False |
| locations[4].source.issn_l | |
| locations[4].source.is_core | False |
| locations[4].source.is_in_doaj | False |
| locations[4].source.display_name | Europe PMC (PubMed Central) |
| locations[4].source.host_organization | https://openalex.org/I1303153112 |
| locations[4].source.host_organization_name | European Bioinformatics Institute |
| locations[4].source.host_organization_lineage | https://openalex.org/I1303153112 |
| locations[4].license | cc-by |
| locations[4].pdf_url | |
| locations[4].version | submittedVersion |
| locations[4].raw_type | Text |
| locations[4].license_id | https://openalex.org/licenses/cc-by |
| locations[4].is_accepted | False |
| locations[4].is_published | False |
| locations[4].raw_source_name | |
| locations[4].landing_page_url | http://europepmc.org/pmc/articles/PMC7847338 |
| locations[5].id | pmh:oai:pubmedcentral.nih.gov:7847338 |
| locations[5].is_oa | True |
| locations[5].source.id | https://openalex.org/S2764455111 |
| locations[5].source.issn | |
| locations[5].source.type | repository |
| locations[5].source.is_oa | False |
| locations[5].source.issn_l | |
| locations[5].source.is_core | False |
| locations[5].source.is_in_doaj | False |
| locations[5].source.display_name | PubMed Central |
| locations[5].source.host_organization | https://openalex.org/I1299303238 |
| locations[5].source.host_organization_name | National Institutes of Health |
| locations[5].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[5].license | cc-by |
| locations[5].pdf_url | |
| locations[5].version | submittedVersion |
| locations[5].raw_type | Text |
| locations[5].license_id | https://openalex.org/licenses/cc-by |
| locations[5].is_accepted | False |
| locations[5].is_published | False |
| locations[5].raw_source_name | J Oncol |
| locations[5].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/7847338 |
| indexed_in | crossref, doaj, pubmed |
| authorships[0].author.id | https://openalex.org/A5064628495 |
| authorships[0].author.orcid | https://orcid.org/0000-0001-8120-7123 |
| authorships[0].author.display_name | Erkan Topkan |
| authorships[0].countries | TR |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I188740104 |
| authorships[0].affiliations[0].raw_affiliation_string | Baskent University Medical Faculty, Department of Radiation Oncology, Baskent University, Adana, Turkey |
| authorships[0].institutions[0].id | https://openalex.org/I188740104 |
| authorships[0].institutions[0].ror | https://ror.org/02v9bqx10 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I188740104 |
| authorships[0].institutions[0].country_code | TR |
| authorships[0].institutions[0].display_name | Başkent University |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Erkan Topkan |
| authorships[0].is_corresponding | True |
| authorships[0].raw_affiliation_strings | Baskent University Medical Faculty, Department of Radiation Oncology, Baskent University, Adana, Turkey |
| authorships[1].author.id | https://openalex.org/A5014100095 |
| authorships[1].author.orcid | https://orcid.org/0000-0001-8087-3140 |
| authorships[1].author.display_name | Uğur Selek |
| authorships[1].countries | TR, US |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I1343551460 |
| authorships[1].affiliations[0].raw_affiliation_string | Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA |
| authorships[1].affiliations[1].institution_ids | https://openalex.org/I1351752 |
| authorships[1].affiliations[1].raw_affiliation_string | Koc University Faculty of Medicine, Department of Radiation Oncology, Koc University, Istanbul, Turkey |
| authorships[1].institutions[0].id | https://openalex.org/I1351752 |
| authorships[1].institutions[0].ror | https://ror.org/00jzwgz36 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I1351752 |
| authorships[1].institutions[0].country_code | TR |
| authorships[1].institutions[0].display_name | Koç University |
| authorships[1].institutions[1].id | https://openalex.org/I1343551460 |
| authorships[1].institutions[1].ror | https://ror.org/04twxam07 |
| authorships[1].institutions[1].type | healthcare |
| authorships[1].institutions[1].lineage | https://openalex.org/I1343551460 |
| authorships[1].institutions[1].country_code | US |
| authorships[1].institutions[1].display_name | The University of Texas MD Anderson Cancer Center |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Ugur Selek |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA, Koc University Faculty of Medicine, Department of Radiation Oncology, Koc University, Istanbul, Turkey |
| authorships[2].author.id | https://openalex.org/A5021976790 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-5361-364X |
| authorships[2].author.display_name | Ahmet Küçük |
| authorships[2].countries | TR |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I51780484 |
| authorships[2].affiliations[0].raw_affiliation_string | Mersin City Hospital, Radiation Oncology Clinics, Mersin, Turkey |
| authorships[2].institutions[0].id | https://openalex.org/I51780484 |
| authorships[2].institutions[0].ror | https://ror.org/04nqdwb39 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I51780484 |
| authorships[2].institutions[0].country_code | TR |
| authorships[2].institutions[0].display_name | Mersin Üniversitesi |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Ahmet Kucuk |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Mersin City Hospital, Radiation Oncology Clinics, Mersin, Turkey |
| authorships[3].author.id | https://openalex.org/A5002758866 |
| authorships[3].author.orcid | https://orcid.org/0000-0001-5124-8362 |
| authorships[3].author.display_name | Veysel Haksöyler |
| authorships[3].affiliations[0].raw_affiliation_string | Medline Hospital, Clinics of Medical Oncology, Adana, Turkey |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Veysel Haksoyler |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Medline Hospital, Clinics of Medical Oncology, Adana, Turkey |
| authorships[4].author.id | https://openalex.org/A5077243451 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-2218-2074 |
| authorships[4].author.display_name | Yurday Özdemir |
| authorships[4].countries | TR |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I188740104 |
| authorships[4].affiliations[0].raw_affiliation_string | Baskent University Medical Faculty, Department of Radiation Oncology, Baskent University, Adana, Turkey |
| authorships[4].institutions[0].id | https://openalex.org/I188740104 |
| authorships[4].institutions[0].ror | https://ror.org/02v9bqx10 |
| authorships[4].institutions[0].type | education |
| authorships[4].institutions[0].lineage | https://openalex.org/I188740104 |
| authorships[4].institutions[0].country_code | TR |
| authorships[4].institutions[0].display_name | Başkent University |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Yurday Ozdemir |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Baskent University Medical Faculty, Department of Radiation Oncology, Baskent University, Adana, Turkey |
| authorships[5].author.id | https://openalex.org/A5014719026 |
| authorships[5].author.orcid | https://orcid.org/0000-0002-4505-2280 |
| authorships[5].author.display_name | Duygu Sezen |
| authorships[5].countries | TR |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I1351752 |
| authorships[5].affiliations[0].raw_affiliation_string | Koc University Faculty of Medicine, Department of Radiation Oncology, Koc University, Istanbul, Turkey |
| authorships[5].institutions[0].id | https://openalex.org/I1351752 |
| authorships[5].institutions[0].ror | https://ror.org/00jzwgz36 |
| authorships[5].institutions[0].type | education |
| authorships[5].institutions[0].lineage | https://openalex.org/I1351752 |
| authorships[5].institutions[0].country_code | TR |
| authorships[5].institutions[0].display_name | Koç University |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Duygu Sezen |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Koc University Faculty of Medicine, Department of Radiation Oncology, Koc University, Istanbul, Turkey |
| authorships[6].author.id | https://openalex.org/A5054114483 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-1932-9784 |
| authorships[6].author.display_name | Hüseyin Mertsoylu |
| authorships[6].countries | TR |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I188740104 |
| authorships[6].affiliations[0].raw_affiliation_string | Baskent University Medical Faculty, Department of Medical Oncology, Baskent University, Adana, Turkey |
| authorships[6].institutions[0].id | https://openalex.org/I188740104 |
| authorships[6].institutions[0].ror | https://ror.org/02v9bqx10 |
| authorships[6].institutions[0].type | education |
| authorships[6].institutions[0].lineage | https://openalex.org/I188740104 |
| authorships[6].institutions[0].country_code | TR |
| authorships[6].institutions[0].display_name | Başkent University |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Huseyin Mertsoylu |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Baskent University Medical Faculty, Department of Medical Oncology, Baskent University, Adana, Turkey |
| authorships[7].author.id | https://openalex.org/A5091755962 |
| authorships[7].author.orcid | https://orcid.org/0000-0002-7862-0192 |
| authorships[7].author.display_name | Ali Ayberk Beşen |
| authorships[7].countries | TR |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I188740104 |
| authorships[7].affiliations[0].raw_affiliation_string | Baskent University Medical Faculty, Department of Medical Oncology, Baskent University, Adana, Turkey |
| authorships[7].institutions[0].id | https://openalex.org/I188740104 |
| authorships[7].institutions[0].ror | https://ror.org/02v9bqx10 |
| authorships[7].institutions[0].type | education |
| authorships[7].institutions[0].lineage | https://openalex.org/I188740104 |
| authorships[7].institutions[0].country_code | TR |
| authorships[7].institutions[0].display_name | Başkent University |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Ali Ayberk Besen |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Baskent University Medical Faculty, Department of Medical Oncology, Baskent University, Adana, Turkey |
| authorships[8].author.id | https://openalex.org/A5079606935 |
| authorships[8].author.orcid | https://orcid.org/0000-0002-3170-5826 |
| authorships[8].author.display_name | Yasemin Bölükbaşı |
| authorships[8].countries | TR, US |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I1351752 |
| authorships[8].affiliations[0].raw_affiliation_string | Koc University Faculty of Medicine, Department of Radiation Oncology, Koc University, Istanbul, Turkey |
| authorships[8].affiliations[1].institution_ids | https://openalex.org/I1343551460 |
| authorships[8].affiliations[1].raw_affiliation_string | Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA |
| authorships[8].institutions[0].id | https://openalex.org/I1351752 |
| authorships[8].institutions[0].ror | https://ror.org/00jzwgz36 |
| authorships[8].institutions[0].type | education |
| authorships[8].institutions[0].lineage | https://openalex.org/I1351752 |
| authorships[8].institutions[0].country_code | TR |
| authorships[8].institutions[0].display_name | Koç University |
| authorships[8].institutions[1].id | https://openalex.org/I1343551460 |
| authorships[8].institutions[1].ror | https://ror.org/04twxam07 |
| authorships[8].institutions[1].type | healthcare |
| authorships[8].institutions[1].lineage | https://openalex.org/I1343551460 |
| authorships[8].institutions[1].country_code | US |
| authorships[8].institutions[1].display_name | The University of Texas MD Anderson Cancer Center |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Yasemin Bolukbasi |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA, Koc University Faculty of Medicine, Department of Radiation Oncology, Koc University, Istanbul, Turkey |
| authorships[9].author.id | https://openalex.org/A5030366726 |
| authorships[9].author.orcid | https://orcid.org/0000-0001-8825-4918 |
| authorships[9].author.display_name | Özgür Özyılkan |
| authorships[9].affiliations[0].raw_affiliation_string | Medline Hospital, Clinics of Medical Oncology, Adana, Turkey |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Ozgur Ozyilkan |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Medline Hospital, Clinics of Medical Oncology, Adana, Turkey |
| authorships[10].author.id | https://openalex.org/A5044733192 |
| authorships[10].author.orcid | https://orcid.org/0000-0001-8253-488X |
| authorships[10].author.display_name | Berrin Pehlivan |
| authorships[10].countries | TR |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I128277893 |
| authorships[10].affiliations[0].raw_affiliation_string | Department of Radiation Oncology, Bahcesehir University, Istanbul, Turkey |
| authorships[10].institutions[0].id | https://openalex.org/I128277893 |
| authorships[10].institutions[0].ror | https://ror.org/00yze4d93 |
| authorships[10].institutions[0].type | education |
| authorships[10].institutions[0].lineage | https://openalex.org/I128277893 |
| authorships[10].institutions[0].country_code | TR |
| authorships[10].institutions[0].display_name | Bahçeşehir University |
| authorships[10].author_position | last |
| authorships[10].raw_author_name | Berrin Pehlivan |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | Department of Radiation Oncology, Bahcesehir University, Istanbul, Turkey |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://downloads.hindawi.com/journals/jo/2021/6688138.pdf |
| open_access.oa_status | hybrid |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Prechemoradiotherapy Systemic Inflammation Response Index Stratifies Stage IIIB/C Non-Small-Cell Lung Cancer Patients into Three Prognostic Groups: A Propensity Score-Matching Analysis |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T11355 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 1.0 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2730 |
| primary_topic.subfield.display_name | Oncology |
| primary_topic.display_name | Inflammatory Biomarkers in Disease Prognosis |
| related_works | https://openalex.org/W2026576563, https://openalex.org/W3196761963, https://openalex.org/W2036193982, https://openalex.org/W213628847, https://openalex.org/W3023923059, https://openalex.org/W4232168831, https://openalex.org/W2065417422, https://openalex.org/W4253956144, https://openalex.org/W2994686985, https://openalex.org/W4281722959 |
| cited_by_count | 15 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 1 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 4 |
| counts_by_year[2].year | 2023 |
| counts_by_year[2].cited_by_count | 8 |
| counts_by_year[3].year | 2022 |
| counts_by_year[3].cited_by_count | 1 |
| counts_by_year[4].year | 2021 |
| counts_by_year[4].cited_by_count | 1 |
| locations_count | 6 |
| best_oa_location.id | doi:10.1155/2021/6688138 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S207014961 |
| best_oa_location.source.issn | 1687-8450, 1687-8469 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 1687-8450 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Journal of Oncology |
| best_oa_location.source.host_organization | https://openalex.org/P4310319869 |
| best_oa_location.source.host_organization_name | Hindawi Publishing Corporation |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310319869 |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://downloads.hindawi.com/journals/jo/2021/6688138.pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Journal of Oncology |
| best_oa_location.landing_page_url | https://doi.org/10.1155/2021/6688138 |
| primary_location.id | doi:10.1155/2021/6688138 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S207014961 |
| primary_location.source.issn | 1687-8450, 1687-8469 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 1687-8450 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Journal of Oncology |
| primary_location.source.host_organization | https://openalex.org/P4310319869 |
| primary_location.source.host_organization_name | Hindawi Publishing Corporation |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310319869 |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://downloads.hindawi.com/journals/jo/2021/6688138.pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Journal of Oncology |
| primary_location.landing_page_url | https://doi.org/10.1155/2021/6688138 |
| publication_date | 2021-01-23 |
| publication_year | 2021 |
| referenced_works | https://openalex.org/W1944220675, https://openalex.org/W2152939220, https://openalex.org/W2902551991, https://openalex.org/W1968899146, https://openalex.org/W1976748562, https://openalex.org/W2117692326, https://openalex.org/W2161816741, https://openalex.org/W2009821632, https://openalex.org/W2055480917, https://openalex.org/W1903495021, https://openalex.org/W2767077750, https://openalex.org/W2895399594, https://openalex.org/W2345885627, https://openalex.org/W2946609094, https://openalex.org/W2908696407, https://openalex.org/W2605172958, https://openalex.org/W2888712518, https://openalex.org/W2900242958, https://openalex.org/W2150721526, https://openalex.org/W2102144390, https://openalex.org/W2898518980, https://openalex.org/W2228221433, https://openalex.org/W2980793254, https://openalex.org/W2962075702, https://openalex.org/W2889205080, https://openalex.org/W2789677706, https://openalex.org/W2778813524, https://openalex.org/W2144935259 |
| referenced_works_count | 28 |
| abstract_inverted_index.( | 166, 177, 242 |
| abstract_inverted_index.) | 174, 185 |
| abstract_inverted_index.1 | 97, 99 |
| abstract_inverted_index.: | 98 |
| abstract_inverted_index.= | 146, 153 |
| abstract_inverted_index.(N | 145, 152 |
| abstract_inverted_index.In | 255 |
| abstract_inverted_index.OS | 118, 165, 251, 284 |
| abstract_inverted_index.We | 1 |
| abstract_inverted_index.an | 111 |
| abstract_inverted_index.at | 115 |
| abstract_inverted_index.by | 95 |
| abstract_inverted_index.in | 240 |
| abstract_inverted_index.of | 6, 17, 45, 195 |
| abstract_inverted_index.on | 13 |
| abstract_inverted_index.or | 232 |
| abstract_inverted_index.to | 54, 82, 87 |
| abstract_inverted_index.we | 134 |
| abstract_inverted_index.1.9 | 116, 144, 151, 159, 190, 231, 265, 279 |
| abstract_inverted_index.876 | 36 |
| abstract_inverted_index.PFS | 126, 176, 286 |
| abstract_inverted_index.PSM | 140 |
| abstract_inverted_index.The | 56, 104, 156, 192, 276 |
| abstract_inverted_index.and | 58, 68, 71, 86, 125, 133, 148, 175, 205, 209, 212, 220, 228, 234, 252, 260, 267, 285, 288 |
| abstract_inverted_index.for | 79, 84, 117, 250 |
| abstract_inverted_index.had | 161, 217 |
| abstract_inverted_index.per | 263 |
| abstract_inverted_index.the | 3, 7, 14, 62, 65, 92, 136, 202, 218, 258, 264, 290 |
| abstract_inverted_index.two | 139 |
| abstract_inverted_index.who | 25, 41 |
| abstract_inverted_index.≥ | 150, 158, 214, 230, 278 |
| abstract_inverted_index.< | 143, 189, 207, 236 |
| abstract_inverted_index.(OS) | 70 |
| abstract_inverted_index.1.9) | 208, 215, 237 |
| abstract_inverted_index.2007 | 53 |
| abstract_inverted_index.304) | 147 |
| abstract_inverted_index.IIIC | 233 |
| abstract_inverted_index.PFS, | 253 |
| abstract_inverted_index.SIRI | 66, 80, 93, 113, 142, 149, 157, 188, 196, 206, 213, 229, 235, 268, 277 |
| abstract_inverted_index.best | 219 |
| abstract_inverted_index.from | 52 |
| abstract_inverted_index.into | 138, 294 |
| abstract_inverted_index.lung | 21 |
| abstract_inverted_index.than | 186 |
| abstract_inverted_index.that | 201 |
| abstract_inverted_index.two- | 259 |
| abstract_inverted_index.were | 61, 77 |
| abstract_inverted_index.with | 49, 197, 224 |
| abstract_inverted_index.(AUC: | 119, 127 |
| abstract_inverted_index.(IIIB | 204, 227 |
| abstract_inverted_index.(IIIC | 211 |
| abstract_inverted_index.(PSM) | 33 |
| abstract_inverted_index.1–3 | 43 |
| abstract_inverted_index.2017. | 55 |
| abstract_inverted_index.304), | 154 |
| abstract_inverted_index.NSCLC | 39 |
| abstract_inverted_index.being | 238 |
| abstract_inverted_index.curve | 108 |
| abstract_inverted_index.index | 11 |
| abstract_inverted_index.stage | 18, 37, 199, 291 |
| abstract_inverted_index.study | 101 |
| abstract_inverted_index.their | 187, 271 |
| abstract_inverted_index.three | 295 |
| abstract_inverted_index.worse | 163, 283 |
| abstract_inverted_index.worst | 221 |
| abstract_inverted_index.(SIRI) | 12 |
| abstract_inverted_index.70.7%) | 124 |
| abstract_inverted_index.72.9%) | 132 |
| abstract_inverted_index.73.7%; | 122 |
| abstract_inverted_index.75.8%; | 130 |
| abstract_inverted_index.78.8%; | 120 |
| abstract_inverted_index.80.5%; | 128 |
| abstract_inverted_index.IIIB/C | 19, 38, 292 |
| abstract_inverted_index.SIRI-1 | 203 |
| abstract_inverted_index.SIRI-2 | 225 |
| abstract_inverted_index.SIRI-3 | 210 |
| abstract_inverted_index.adjust | 83 |
| abstract_inverted_index.cancer | 22 |
| abstract_inverted_index.cohort | 160, 226 |
| abstract_inverted_index.cutoff | 114 |
| abstract_inverted_index.cycles | 44 |
| abstract_inverted_index.groups | 81, 94, 269 |
| abstract_inverted_index.median | 164 |
| abstract_inverted_index.plated | 289 |
| abstract_inverted_index.scores | 76 |
| abstract_inverted_index.values | 67 |
| abstract_inverted_index.(NSCLC) | 23 |
| abstract_inverted_index.<a:math | 167 |
| abstract_inverted_index.<c:math | 178 |
| abstract_inverted_index.<e:math | 243 |
| abstract_inverted_index.Present | 30 |
| abstract_inverted_index.between | 64, 91, 241 |
| abstract_inverted_index.cohorts | 216 |
| abstract_inverted_index.cutoffs | 266 |
| abstract_inverted_index.disease | 198 |
| abstract_inverted_index.further | 193 |
| abstract_inverted_index.grouped | 135 |
| abstract_inverted_index.groups. | 102, 299 |
| abstract_inverted_index.matched | 100 |
| abstract_inverted_index.optimal | 112 |
| abstract_inverted_index.overall | 69 |
| abstract_inverted_index.primary | 57 |
| abstract_inverted_index.results | 287 |
| abstract_inverted_index.Methods. | 29 |
| abstract_inverted_index.Purpose. | 0 |
| abstract_inverted_index.Results. | 103 |
| abstract_inverted_index.analysis | 34, 109 |
| abstract_inverted_index.cohorts: | 141 |
| abstract_inverted_index.creating | 96 |
| abstract_inverted_index.distinct | 297 |
| abstract_inverted_index.doublets | 47 |
| abstract_inverted_index.explored | 2 |
| abstract_inverted_index.id="M1"> | 169 |
| abstract_inverted_index.id="M2"> | 180 |
| abstract_inverted_index.id="M3"> | 245 |
| abstract_inverted_index.outcomes | 16 |
| abstract_inverted_index.patients | 24, 40, 137, 293 |
| abstract_inverted_index.received | 42 |
| abstract_inverted_index.receiver | 105 |
| abstract_inverted_index.remained | 239 |
| abstract_inverted_index.response | 10 |
| abstract_inverted_index.retained | 270 |
| abstract_inverted_index.survival | 15 |
| abstract_inverted_index.systemic | 8 |
| abstract_inverted_index.thoracic | 50 |
| abstract_inverted_index.</a:math> | 173 |
| abstract_inverted_index.</c:math> | 184 |
| abstract_inverted_index.</e:math> | 249 |
| abstract_inverted_index.analysis, | 257 |
| abstract_inverted_index.comprised | 35 |
| abstract_inverted_index.exhibited | 200 |
| abstract_inverted_index.influence | 5 |
| abstract_inverted_index.operating | 106 |
| abstract_inverted_index.outcomes, | 222 |
| abstract_inverted_index.secondary | 59 |
| abstract_inverted_index.survival, | 73 |
| abstract_inverted_index.underwent | 26 |
| abstract_inverted_index.Propensity | 75 |
| abstract_inverted_index.calculated | 78 |
| abstract_inverted_index.concurrent | 27, 48 |
| abstract_inverted_index.facilitate | 88 |
| abstract_inverted_index.identified | 110 |
| abstract_inverted_index.objectives | 60 |
| abstract_inverted_index.prognostic | 4, 298 |
| abstract_inverted_index.propensity | 31 |
| abstract_inverted_index.combination | 194 |
| abstract_inverted_index.companions. | 191 |
| abstract_inverted_index.confounders | 85 |
| abstract_inverted_index.independent | 272 |
| abstract_inverted_index.Conclusions. | 275 |
| abstract_inverted_index.inflammation | 9 |
| abstract_inverted_index.multivariate | 256 |
| abstract_inverted_index.radiotherapy | 51 |
| abstract_inverted_index.sensitivity: | 121, 129 |
| abstract_inverted_index.separately). | 254 |
| abstract_inverted_index.specificity: | 123, 131 |
| abstract_inverted_index.comparability | 90 |
| abstract_inverted_index.fundamentally | 296 |
| abstract_inverted_index.independently | 280 |
| abstract_inverted_index.individually. | 274 |
| abstract_inverted_index.relationships | 63 |
| abstract_inverted_index.respectively, | 223 |
| abstract_inverted_index.respectively. | 74, 155 |
| abstract_inverted_index.significance, | 273 |
| abstract_inverted_index.significantly | 162, 282 |
| abstract_inverted_index.well-balanced | 89 |
| abstract_inverted_index.<a:mi>P</a:mi> | 170 |
| abstract_inverted_index.<c:mi>P</c:mi> | 181 |
| abstract_inverted_index.<e:mi>P</e:mi> | 246 |
| abstract_inverted_index.characteristic | 107 |
| abstract_inverted_index.non-small-cell | 20 |
| abstract_inverted_index.platinum-based | 46 |
| abstract_inverted_index.prognosticated | 281 |
| abstract_inverted_index.score-matching | 32 |
| abstract_inverted_index.three-laddered | 261 |
| abstract_inverted_index.stratifications | 262 |
| abstract_inverted_index.progression-free | 72 |
| abstract_inverted_index.<a:mo><</a:mo> | 171 |
| abstract_inverted_index.<c:mo><</c:mo> | 182 |
| abstract_inverted_index.<e:mo><</e:mo> | 247 |
| abstract_inverted_index.<a:mn>0.001</a:mn> | 172 |
| abstract_inverted_index.<c:mn>0.001</c:mn> | 183 |
| abstract_inverted_index.<e:mn>0.001</e:mn> | 248 |
| abstract_inverted_index.chemoradiotherapy. | 28 |
| abstract_inverted_index.xmlns:a="http://www.w3.org/1998/Math/MathML" | 168 |
| abstract_inverted_index.xmlns:c="http://www.w3.org/1998/Math/MathML" | 179 |
| abstract_inverted_index.xmlns:e="http://www.w3.org/1998/Math/MathML" | 244 |
| cited_by_percentile_year.max | 99 |
| cited_by_percentile_year.min | 89 |
| corresponding_author_ids | https://openalex.org/A5064628495 |
| countries_distinct_count | 2 |
| institutions_distinct_count | 11 |
| corresponding_institution_ids | https://openalex.org/I188740104 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.8299999833106995 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.82717348 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |